EPISTAXIS

Clinical trials for EPISTAXIS explained in plain language.

Never miss a new study

Get alerted when new EPISTAXIS trials appear

Sign up with your email to follow new studies for EPISTAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1 Completed 2

New ointment could tame HHT nosebleeds

Symptom relief Recruiting now

This early-phase trial tests a new nasal ointment called TOR-582, which contains sirolimus, in 27 adults with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Participants apply the ointment inside their nostrils twice daily for 12 weeks, with different s…

Matched conditions: EPISTAXIS

Phase: PHASE1 • Sponsor: Columbia University • Aim: Symptom relief

Last updated Jun 27, 2026 14:01 UTC

EPISTAXIS

Get alerted when new EPISTAXIS trials appear

New ointment could tame HHT nosebleeds